Browsing by Subject Trastorns del metabolisme dels lípids

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)
30-Sep-1990Abnormalities of lipoprotein metabolism in patients with the nephrotic syndromeJoven, Jorge; Villabona Artero, Carlos; Vilella, Elisabet; Masana, Luis; Albertí, Rosa; Vallés, Martin
16-May-2016Associations between whole peripheral blood fatty acids and DNA methylation in humansRocha, Carmen de la; Pérez-Mojica, J. Eduardo; Zenteno-De León, Silvia; Cervantes-Paz, Braulio; Tristán-Flores, Fabiola E.; Rodríguez-Ríos, Dalia; Molina-Torres, Jorge; Ramírez-Chávez, Enrique; Alvarado-Caudillo, Yolanda; Carmona, F. Javier; Esteller, Manel; Hernández-Rivas, Rosaura; Wrobel, Katarzyna; Wrobel, Kazimierz; Zaina, Silvio; Lund, Gertrud
1-May-2021Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupusFanlo Maresma, Marta; Candás Estébanez, Beatriz; Esteve Luque, Virginia; Padró i Miquel, Ariadna; Escrihuela Vidal, Francesc; Carratini-Moraes, Monica; Corbella, Emili; Corbella, Xavier; Pintó Sala, Xavier
27-Sep-2012Comorbilitats associades a l'obesitat mòrbida i la seva evolució amb la cirurgia bariàtrica: diabetis, dislipèmia i esteatosi hepàticaPardina Arrese, Eva
17-Apr-2013Convenient synthesis of C75, an inhibitor of FAS and CPT1Sánchez Zarzalejo, Carolina; Makowski, Kamil; Mera Nanín, Paula; Farràs i Soler, Jaume; Nicolás Galindo, Ernesto; Herrero Rodríguez, Laura; Asins Muñoz, Guillermina; Serra i Cucurull, Dolors; García Hegardt, Fausto; Ariza Piquer, Xavier; García Gómez, Jordi
21-Nov-2022CPT1AM overexpression in BAT from HFD-treated mice prevents the induction of obesity and associated diabetesBastías Pérez, Marianela Pía
25-Jan-2022Effect of Continuous Positive Airway Pressure on Lipid Profiles in Obstructive Sleep Apnea: A Meta-AnalysisChen, Baixin; Guo, Miaolan; Peker, Yüksel; Salord, Neus; Drager, Luciano F.; Lorenzi-Filho, Geraldo; Tang, Xiangdong; Li, Yun
11-Sep-2014Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: a single-arm intervention trialLeyes, Pere; Martínez Chamorro, Esteban José; Larrousse Morellón, Maria; Cofán Pujol, Montserrat; Trabal, Joan; Pérez-Heras, Ana Maria; Forga, María T.; Ros Rahola, Emilio
1-Mar-2000Epidermal growth factor secreted from submandibular salivary glands interferes with the lipolytic effect of adrenaline in miceTebar Ramon, Francesc; Grau, Montserrat; Mena Jaramillo, Mari Pau; Arnau, Anna; Soley i Farrés, María; Ramírez i Sunyer, Josep Ignasi
3-Feb-2009Estrès oxidatiu i peroxidació lipídica en el pacient nefròpataRamos Sánchez, Rosa
26-Jan-2021Estudio de la relación entre la obesidad y sobrepeso en pacientes con cáncer de mama en centro hospitalario oncológicoMacias Montes, Helena
16-Jul-2021GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPKAguilar-Recarte, David; Barroso Fernández, Emma; Gumà i Garcia, Anna Maria; Pizarro Delgado, Javier; Peña, Lucía; Ruart, Maria; Palomer Tarridas, Francesc Xavier; Wahli, Walter; Vázquez Carrera, Manuel
2018Hepatic regulation of VLDL receptor by PPARbeta/delta and FGF21 modulates non-alcoholic fatty liver diseaseZarei, Mohammad; Barroso Fernández, Emma; Palomer Tarridas, Francesc Xavier; Dai, Jianli; Rada, Patricia; Quesada López, Tania Paloma; Escolà Gil, Joan Carles; Cedó Giné, Lídia; Zali, Mohammad Reza; Molaei, Mahsa; Dabiri, Reza; Vázquez Cruz, Santiago; Pujol Bech, Eugènia; Valverde, Ángela M.; Villarroya i Gombau, Francesc; Liu, Yong; Wahli, Walter; Vázquez Carrera, Manuel
2011Liver Glucokinase A456V induces potent hypoglycemia without dyslipidemia through a paradoxical induction of the catalytic subunit of glucose-6-phosphataseVidal Alabró, Anna; Gómez Valadés, Alicia G.; Méndez-Lucas, Andrés; Llorens i Baucells, Jordi; Bartrons Bach, Ramon; Bermúdez i Mas, Jordi; Perales Losa, Carlos
22-Dec-2022New therapeutic approaches to modulate metabolic alterations in the cardiovascular system. In vivo studiesBenítez Amaro, Aleyda
3-Feb-2012Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for DyslipidemiaBarroso Fernández, Emma; Serrano-Marco, Lucía; Salvadó Serra, Laia; Palomer Tarridas, Francesc Xavier; Vázquez Carrera, Manuel
2010Preparation of alpha-labeled aldehydes by base-catalyzed exchange reactionsAriza Piquer, Xavier; Asins Muñoz, Guillermina; García Gómez, Jordi; García Hegardt, Fausto; Makowski, Kamil; Serra i Cucurull, Dolors; Velasco Turbau, Javier
17-Jul-2012Que hay que saber para implementar el servicio de Atención Farmacéutica al paciente con riesgo cardiovascularVia Sosa, Ma. de los Ángeles; March Pujol, Marian; Travé i Mercadé, Pere; Fuentes Almendras, Miriam; Badía Palacín, Josefa
7-Mar-2022Reduced plasma extracellular vesicle CD5L content in patients with acute-on-chronic liver failure: interplay with specialized pro-resolving lipid mediators.Sánchez Rodríguez, María Belén; Téllez, Erica; Casulleras, Mireia; Borràs, Francesc E.; Arroyo, Vicente; Clària i Enrich, Joan; Sarrias Fornés, Maria Rosa
9-Aug-2021The PPARβ/δ-AMPK Connection in the Treatment of Insulin ResistanceAguilar-Recarte, David; Palomer Tarridas, Francesc Xavier; Wahli, Walter; Vázquez Carrera, Manuel